At one time, natural killer cells were thought of as a small group of specialized immune cells that can rapidly identify and destroy cells that have been infected with a virus. But research has shown ...
clonoSEQ identifies and quantifies DNA sequences in malignant cells—detecting one cancer cell in one million healthy cells—to help clinicians and researchers assess and monitor MRD with precision over ...
Children have largely avoided severe COVID-19 symptoms because they have a strong initial 'innate' immune reaction that quickly defeats the virus. And now, researchers led by scientists at the Garvan ...
Research demonstrates the ability of Adaptive’s immune medicine platform to distinguish natural infection from vaccine response and the ability to detect prior infection nearly 12 months after initial ...
In a recent perspective review, researchers attempt to collate and discuss scientific knowledge on the concept of the ‘immune self’ and use raw T cell assays, nine amino-long pathogen-derived peptides ...
Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic. In the years that followed, other groups ...
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical ...
“We know for multiple reasons why smoking is bad in terms of its cancer risk, but here we're showing additional information that it's also probably negatively impacting your immune response. And that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results